Skip to Content

About the Study

The VALOR Study is being done to see if an investigational medicine can be safely given to infants, children, and teenagers and if it may help improve their heart failure.

  • There will be about 342 participants from around the world.
  • Children with heart failure who are between the ages of 29 days to 17 years (before 18th birthday) may be eligible to join the study.
  • There are other requirements to join the study. Your child’s cardiologist can help you decide if your child may be eligible.

What happens during the VALOR Study?

The study lasts about 1 year. It has three parts. In total, there will be about 12 scheduled visits to the study clinic.

What happens at study visits?

Your child will have health checks and tests at study visits. The study doctor will also talk to you and your child and ask questions. The information will help the researchers understand if the study medicine may safely help children with heart failure.

You’ll be familiar with most of the tests. Some tests will only be done a few times during the study.

""

Blood Tests
Blood samples will be taken at approximately 7 visits.



""

Heart Activity
An ECG heart test will be done at 5 visits.

""

Physical Exam
A complete physical exam will be done at the first and final clinic visits.

What is the study medicine?

The study medicine, vericiguat, is being compared to a placebo. The placebo looks just like vericiguat, but has no active ingredients.

The study medicine comes as a liquid or tablet to be taken once a day with food. Whether your child gets the liquid or tablet will depend on their weight. The medicine should be taken approximately at the same time each day (about every 24 hours). Your child will continue to take their usual medicines as well.

Study Locations

Locations shown may have changed in some cases. Please call the number listed in the location results to confirm the nearest study site. Talk with a study site member for more information.

|

General Study Questions

Talk to your child’s cardiologist about the VALOR Study. They’ll be able to answer your questions or reach out to a VALOR study doctor to find out more.

There are risks and benefits to being in any clinical study, which a study doctor can discuss with you in greater detail. The study doctor and study team will answer any questions you may have and review eligibility criteria to see if your child may be eligible to participate.

No. Your child will continue to take their usual medicines.

Your child must be less than 18 years old at the time you sign the Informed Consent Form (the document that shows you agree to your child participating in the study). A child who turns 18 during their participation in the study can remain in the study.

Understanding clinical studies is important when making a decision about joining one. Our FAQs have answers to common questions for parents and children. See more at the link below.

What can you do next?

If you think this clinical trial might be a good fit and you are interested in taking part, take the next step to see if you are eligible.

Discuss with your child’s doctor or care team

Print this page with details about the study or email it to your child’s doctor to discuss the clinical study during your child’s next visit.

Get help talking with your child’s doctor or care team

Contact our Study Information Center

To learn more, call 1-888-577-8839.

NATIONAL TRIAL REFERENCE NUMBER

NCT05714085

EudraCT Number

2021-004399-33

When you talk with your doctor or clinical trial team member, please have the national trial reference number available.

Deciding to allow your child to take part in a clinical study is an important decision.
If you are considering whether your child will join a clinical study, learn as much as you can about:

  • The investigational treatment that is being studied
  • What the possible risks and benefits are for your child

Talk to your child’s doctor about the clinical study before you decide whether they will join.